Lesions in nanolcoholic fatty liver disease
Bedossa, P.
La Revue du Praticien 62(10): 1419
2012
ISSN/ISBN: 0035-2640 PMID: 23424925 Document Number: 659819
Document emailed within 1 workday
Related Documents
Jin, H-Bin.; Gu, Z-Ying.; Yu, C-Hui.; Li, Y-Ming. 2005: Association of nonalcoholic fatty liver disease with type 2 diabetes: clinical features and independent risk factors in diabetic fatty liver patients Hepatobiliary and Pancreatic Diseases International: Hbpd Int 4(3): 389-392Zhu, Q.-q.; Lou, D.-j.; Si, X.-w.; Guan, L.-l.; You, Q.-y.; Yu, Z.-m.; Zhang, A.-z.; Li, D. 2010: Serum omega-3 polyunsaturated fatty acid and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease Zhonghua Nei Ke Za Zhi 49(4): 305-308
Aller, R.; De Luis, D.A.; Fernandez, L.; Calle, F.; Velayos, B.; Izaola, O.; Gonzalez Sagrado, M.; Conde, R.; Gonzalez, J.M. 2009: Influence of Ala54Thr polymorphism of fatty acid-binding protein 2 on histological alterations and insulin resistance of non alcoholic fatty liver disease European Review for Medical and Pharmacological Sciences 13(5): 357-364
Joos, W.; Mörl, M. 1984: Alcohol-induced organic lesions. 3. Liver damage - alcoholic fatty liver, alcoholic hepatitis, acute and chronic clinical course Fortschritte der Medizin 102(4): 79-82
Jiménez, M.M.; Gallego, M.S.; Lozano, F.; Blanco, E.; Alloza, M. 2000: Focal fatty liver lesions: infrequent ultrasonographic presentation Gastroenterologia y Hepatologia 23(5): 234-236
Chen, J.; Zheng, R.-D.; Xu, C.-R.; Wu, W.-P. 2009: Expression and significance of liver X receptor-alpha in nonalcoholic fatty liver disease in rats Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 23(4): 265-268
Chen, L.-l.; Deng, X.-q.; Li, N.-x. 2007: Effects of calorie restriction on SIRT1 expression in liver of nonalcoholic fatty liver disease: experiment with rats Zhonghua Yi Xue Za Zhi 87(20): 1434-1437
Mori, M.; Yokoyama, M.; Yokoyama, S.; Onoe, T. 1974: Electron microscopic study of the development of fatty liver. II. Fatty liver associated with low dietary intake of proteins Hokkaido Journal of Medical Science 49(2): 161-162
Vogelberg, K.H.; Gisbertz, K.H.; Moschinsky, D.; Both, A.; Bostroem, B.; Kübler, W.; Gries, F.A. 1974: Effect of insulin on fatty acid metabolism in the liver in endogenous hypertriglyceridemia. Findings on the uptake of free fatty acids and ketone body production of the liver Verhandlungen der Deutschen Gesellschaft für Innere Medizin 80: 1264-1266
Sdiri, W.; Romdhane, H.; Mbarek, D.; Ben Abdallah, H.; Longo, S.; Abdelli, M.N.; Boujnah, M.R. 2013: Non alcoholic fatty liver disease: a new risk factor for cardiovascular disease? La Tunisie Medicale 91(3): 171-174
Yoshihara, H.; Sato, N.; Kubota, S.; Inoue, A.; Matsumura, T.; Hayashi, N.; Kawano, S.; Kamada, T. 1985: Serum holo and apo type activity of mitochondrial GOT in patients with alcoholic liver disease--with special reference to alcoholic fatty liver Arukoru Kenkyu to Yakubutsu Izon 20(2): 166-174
Korpraphong, P.; Leyendecker, J.R.; Hildebolt, C.F.; Narra, V.; Bae, K.T.; Brown, J.J. 2009: Serial MR imaging of small arterially-enhancing liver lesions in patients with chronic liver disease Journal of the Medical Association of Thailand 92(4): 548-555
Antelava, N.A.; Gongadze, M.V.; Okudzhava, M.V.; Pachkoriia, K.Z.; Gogolauri, M.I. 2012: Treatment of nonalcogolic fatty disease of liver Georgian Medical News 2012(208-209): 24-30
Dasarathy, J.; Allampati, S.; Alexander, C.; McCullough, A. 2016: Non-alcoholic fatty liver disease: What's in our arsenal? Journal of Family Practice 65(4): 239-244
Fan, J.-G.; Farrell, G.C. 2009: Epidemiology of non-alcoholic fatty liver disease in China Journal of Hepatology 50(1): 204-210
Björklund, J.; Laursen, T.L.; Kazankov, K.; Thomsen, K.L.; Hamilton-Dutoit, S.; Stenbøg, E.; Grønbæk, H. 2017: Non-alcoholic fatty liver disease in children and adolescents Ugeskrift for Laeger 179(27)
Pérez Blanco, L.A.; Vilar Gómez, E.; Martínez Pérez, Y.; Calzadilla Bertot, L. 2013: Nonalcoholic fatty liver disease. a current perspective Acta Gastroenterologica Latinoamericana 43(3): 254-260
Grigor'eva, I.N. 2011: UDCA in the treatment of nonalcoholic fatty liver disease Eksperimental'naia i Klinicheskaia Gastroenterologiia 11: 79-85
Grigor'eva, I.N. 2011: UDCA in the treatment of nonalcoholic fatty liver disease Eksperimental'naia i Klinicheskaia Gastroenterologiia 9: 125-131
Abenavoli, L.; Milic, N.; Luigiano, C. 2014: Low 25-hydroxyvitamin D3 serum levels and non-alcoholic fatty liver disease Minerva Medica 105(2): 175